Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy

Abstract

PCA3 is an useful tool to select patients for IBx. Patients with a calculated probability of having PCa over 40% should be counseled to undergo an IBx if opportunistic screening is required.